Medicaid Care Innovation: The Medical Home Network Story

      
HealthcareWebSummit
 
Home Page  | Upcoming Events  |  Past Events  |  Registration  |   Attendees  |  More Info  |  LinkedIn
 
Preparing for MACRA - The Next Steps: Composite Scoring, Performance Considerations, Implications and More 
 
  Download Brochure Need a brochure? Download the event brochure including a registration form you can fax or mail
     
Overview
On May 9, 2016, the Centers for Medicare & Medicaid Services (“CMS”) published a proposed rule addressing the implementation of physician payment reforms included in the Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”). The proposed rule outlines the CMS framework for the Merit-Based Incentive Payment System (“MIPS”) and physician participation in Advanced Alternative Payment Models (“Advanced APMs”), two programs that intend to shift Medicare physician payments toward payments for value over volume.

MACRA is likely to ultimately be regarded as a watershed moment wherein the fee-for-service Medicare program took on (or even exceeded in granularity) the incentives present in managed care. Previously, a physician practice opted in to payment for performance. PQRS and meaningful use had been, to date, largely reporting incentives and ACO downside risk was both voluntary and relatively rarely attempted. The dawn of MACRA might be seen as CMS crossing the line from being a passive payer to being a demanding customer that changes the specifications of its order and settles its bill according to data it controls well after the date of service.

Now that the comment period has ended for the proposed rule, stakeholders should begin to further position themselves for MACRA in advance of issuance of the final rule later this year, MACRA measurement starting in 2017, and MACRA financial impact starting in 2019. Rather than waiting to see what is in the final rule, stakeholders should take steps now to analyze what their MIPS/APM participation and performance is going to look like.

During this session, a brief overview of the proposed rule, timing for the final rule, and implementation timelines will be discussed. Implications of the MIPS scoring proposal will be addressed, including how to better understand the complex and confusing composite scoring mechanism. The vast majority of physicians and other clinicians should be taking a close look at how performance is defined under each of the four performance categories under MIPS and preparing for participation in MIPS. A laundry list of topics will be covered relating to Quality considerations, Resource Use, Clinical Performance Improvement Activities, Advancing Care Information and additional considerations.

Please join us Thursday August 4th, 2016 at 1 PM Eastern as Epstein Becker Green's Mark Lutes and Lesley Yeung and EBG Advisors' Bob Atlas walk us through a range of preparation issues in the HealthcareWebSummit event: Preparing for MACRA - The Next Steps: Composite Scoring, Performance Considerations, Implications and More.
 
Learning Objectives

After attending this webinar, attendees will be able to:

  1. Consider the steps involved in analyzing what MIPS/APM participation and performance is going to look like 
  2. Ascertain MACRA APM and MIPS components, provisions and timing relating to the proposed rule
  3. Understand key concepts and specifications for the MIPS composite scoring mechanism
  4. Ascertain detailed considerations relating to the four MIPS performance categories
  5. Explore various implications relating to MACRA preparation and implementation
  6. Engage in interactive learning through online question submission, attendee feedback and opportunity for follow up questions, and networking with attendees, faculty and other professionals through dedicated LinkedIn group.
Who Should Attend

Interested attendees would include:

  • C-Suite Executives
  • Healthcare Innovation, Transformation and Reform Executives
  • Healthcare Payment Transformation Executives
  • Legal, Regulatory and Policy Executives and Staff
  • Provider Performance Analytics Executives
  • Provider Relations and Contracting Executives and Staff
  • Provider Network Operations Executives and Staff
  • Finance Executives and Staff
  • Managed Care Executives and Staff
  • Planning and Strategic Executives and Staff
  • Business Intelligence Staff
  • Other Interested Parties

Attendees would represent organizations including:

  • Medical Groups
  • Hospitals and Health Systems
  • Accountable Care Organizations
  • Provider Networks
  • Other Healthcare Providers
  • Health Plans
  • Government
  • Pharmaceutical Organizations
  • Solutions Providers
  • Associations, Institutes and Research Organizations
  • Media
  • Other Interested Organizations
Registration
Preparing for MACRA - The Next Steps: Composite Scoring, Performance Considerations, Implications and More
 
  Individual Registration Fee: $195. Post-event materials, with video syncing slides and recorded audio, plus presentation pdf file: $45 for attendees; $240 for non-attendees after the event. Register online or download the event brochure.
 
 
 
Register Now   Corporate Site licensing also available. Click here to register or call 209.577.4888 We look forward to your participation in this event!
 
 
Faculty
 
Mark E. Lutes

Mark E. Lutes
Chair, Board of Directors; Member of the Firm
Epstein Becker Green

  Mark E. Lutes is a Member of the Firm in the Health Care and Life Sciences practice of Epstein Becker Green and the Chair of the firm's Board of Directors. Based in Washington, DC, he has practiced with the firm for nearly three decades. Prior to that, he was a legislative adviser to the Federal Trade Commission. He also offers strategic counsel in health policy and on reimbursement strategy through the firm's affiliates EBG Advisors, Inc., and National Health Advisors, LLC.

Mr. Lutes is a leader in the firm's representation of private equity and financial services firms with health care companies in their portfolios. He routinely deploys multidisciplinary teams of attorneys, reimbursement specialists, engineers, and scientists to assess the reimbursement, FDA and other domestic and international regulatory approvals, fraud and abuse compliance, CMS and legislative landscapes and other issues impacting proposed client investments in health care companies. Mr. Lutes combines experience with the corporate aspects of transactions with his deep experience in health care compliance issues to provide clients with practical advice in the negotiation of warranty and indemnification issues and in assessing risk factors in health and life science deals. He has advised on the largest transactions in the health care market including services, pharmaceutical and device companies.

Mr. Lutes is also an experienced antitrust counselor to health care companies contemplating mergers or acquisitions and has facilitated the antitrust clearance of numerous significant hospital mergers. He has managed the defense of high profile healthcare antitrust actions by the FTC.

Mr. Lutes has a deep understanding of managed care markets and regulation. He is consulted by a variety of providers and payors in structuring innovative payment arrangements. Additionally, he counsels on hospital and physician ventures and compliance issues and in the area of information privacy and security. Mr. Lutes has developed privacy and security audit tools which support client compliance needs.

He has been selected for inclusion in Washington, DC Super Lawyers (2007 to 2010, 2013, 2014) and honored by Nightingales as a leading health care antitrust lawyer. He is ranked among the "Leaders in Their Field" by Chambers USA (2010 to 2014).

Mr. Lutes is active in his parish and serves as Chair of the Advisory Board of the Spanish Catholic Center, a social and health services nonprofit. He also serves on the President's Council of Catholic Charities, Archdiocese of Washington, DC, which honored him with The Caritas Award, its highest recognition of volunteers. Mr. Lutes also has over a decade of service in leadership in the Boy Scouts of America organization.

 
Lesley R. Yeung

Lesley R. Yeung
Associate
Epstein Becker Green

 

Lesley R. Yeung is an Associate in the Health Care and Life Sciences practice in the firm's Washington, DC, office. Ms. Yeung has been selected to the Washington DC Rising Stars list (2014 to 2016) in the area of Health Care.

Ms. Yeung: Advises health care providers and health-related companies, financial institutions and investors of industry trends and policy developments; Advises hospitals, health systems and other health-related companies on legal and regulatory matters arising under Medicare, Medicaid and other third-party reimbursement programs; Advises clients regarding federal and state health care regulatory issues, including licensing and reimbursement matters associated with change of ownership; and Assists health care providers with government investigations relating to health care fraud and abuse arising under anti-kickback laws, the Stark Law and the False Claims Act.

Ms. Yeung recently served as a law clerk at a large nonprofit membership organization, where she supported litigation efforts related to the provision of long-term care services under the Americans with Disabilities Act. Prior to attending law school, Ms. Yeung was a health insurance specialist at the Centers for Medicare & Medicaid Services. She also previously worked as a program analyst at the Department of Health and Human Services and as a presidential management fellow at the National Institutes of Health.

Ms. Yeung received her J.D. from The George Washington University Law School; her M.P.A. from New York University, Robert F. Wagner Graduate School of Public Service and her B.A. from Boston University. She is a member of the American Bar Association and New York State Bar Association.


 
Bob Atlas

Robert F. Atlas
President and Strategic Advisor
EBG Advisors

 

Bob Atlas is President of EBG Advisors, a health care consultancy affiliated with the law firm of Epstein Becker Green.

Mr. Atlas has nearly four decades of experience as an advisor to senior leaders and governing authorities in the health care industry and the public sector. He consults on strategy, policy analysis, program development, and performance improvement for health care providers, payers, policymakers, product makers, investors, and other stakeholders. He is well regarded for his expertise in managed care and accountable care, health services management, health care finance, and the public insurance programs, Medicaid and Medicare.

Of late, Mr. Atlas has been engaged in governmental health financing innovations. He led a team implementing national health insurance in a Caribbean island nation and is currently engaged with two states’ Medicaid agencies designing coordinated care solutions that feature patient-centered medical homes spanning primary care through long-term services and supports. He is also working with providers, health plans and life sciences companies on deploying value-driven care concepts in sustainable programs.

In the years before joining EBG Advisors, Mr. Atlas was principal executive of three nationally prominent health care consulting firms. Previously, after earning an M.B.A. in Health Administration and Finance from The University of Chicago Booth School of Business, he served as a commissioned officer in the U.S. Public Health Service. He worked in Medicare’s quality-of-care office and in the agency responsible for promoting the growth of health maintenance organizations.

 
HealthcareWebSummit events from MCOL  
1101 Standiford Ave. Suite C-3 Modesto, CA 95350
Phone 209.577.4888  | e-Mail
infohws@healthwebsummit.com  |  Fax 209.577.3557
copyright , MCOL All rights reserved. Terms of Use apply to this site and participation in events.